
Ultramef Plus 80mg/250mg Tablet
Marketer
Ultrascot Biotech Pvt. Ltd.
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Ultramef Plus 80mg/250mg Tablet
Combiflam Plus 80mg/250mg tablets offer relief from abdominal pain. This dual-action medication alleviates bloating, cramping, and discomfort by relaxing gastrointestinal muscles and inhibiting pain-inducing neurotransmitters. Always take Combiflam Plus 80mg/250mg tablets with food, following your doctor's prescribed dosage and regimen. Treatment duration depends on individual response and condition severity; premature discontinuation may lead to symptom recurrence or worsening. Inform your physician of all other medications you are currently using, as interactions are possible. Common side effects include nausea, vomiting, diarrhea, stomach pain, dry mouth, appetite loss, thirst, and heartburn; most subside spontaneously. Report any concerning side effects to your doctor immediately. Dizziness and drowsiness are potential side effects; avoid driving or activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided due to potential increased dizziness. Consult your doctor before use if pregnant, planning pregnancy, breastfeeding, or if you have kidney or liver disease to ensure appropriate dosage.
Primary Ingredients of Ultramef Plus 80mg/250mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Ultramef Plus 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Ultramef Plus 80mg/250mg Tablet:
Consume Ultramef Plus 80mg/250mg Tablet precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Ultramef Plus 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Ultramef Plus 80mg/250mg Tablet:
Consume Ultramef Plus 80mg/250mg Tablets exactly as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication should be administered with food.
How Ultramef Plus 80mg/250mg Tablet works:
Ultramef Plus 80mg/250mg tablets combine drotaverine and mefenamic acid to alleviate abdominal discomfort and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle contractions, easing spasms. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for abdominal pain and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Ultramef Plus 80mg/250mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Ultramef Plus 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Ultramef Plus 80mg/250mg tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Ultramef Plus 80mg/250mg tablets might lead to adverse reactions that impair driving, as the medication can induce dizziness.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Ultramef Plus 80mg/250mg tablets, as dose modification may be necessary. Medical advice is recommended. Ultramef Plus 80mg/250mg tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Ultramef Plus 80mg/250mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Ultramef Plus 80mg/250mg Tablet :
Should you forget a dose of Ultramef Plus 80mg/250mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ultramef Plus 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Gastrointestinal system |
